Pell Bio-Med Technology Balance Sheet Health
Financial Health criteria checks 6/6
Pell Bio-Med Technology has a total shareholder equity of NT$1.4B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.6B and NT$246.2M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.21b |
| Equity | NT$1.38b |
| Total liabilities | NT$246.15m |
| Total assets | NT$1.62b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6949's short term assets (NT$1.2B) exceed its short term liabilities (NT$101.9M).
Long Term Liabilities: 6949's short term assets (NT$1.2B) exceed its long term liabilities (NT$144.2M).
Debt to Equity History and Analysis
Debt Level: 6949 is debt free.
Reducing Debt: 6949 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6949 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6949 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 29.6% each year